Sino Biopharmaceutical Limited (SBMFF) revealed a profit for full year that Drops, from last year
The company's earnings totaled RMB2.343 billion, or RMB0.1302 per share. This compares with RMB3.499 billion, or RMB0.1913 per share, last year.
Excluding items, Sino Biopharmaceutical Limited reported adjusted earnings of RMB4.541 billion or RMB0.2522 per share for the period.
The company's revenue for the period rose 10.3% to RMB31.834 billion from RMB28.866 billion last year.
Sino Biopharmaceutical Limited earnings at a glance (GAAP) :
-Earnings: RMB2.343 Bln. vs. RMB3.499 Bln. last year.-EPS: RMB0.1302 vs. RMB0.1913 last year.-Revenue: RMB31.834 Bln vs. RMB28.866 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.